Cargando…
Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer
CHRDL1 (Chordin-like 1) is a secreted protein that acts as an antagonist of bone morphogenetic protein (BMP). BMP plays a role as an activator of BMP receptor II (BMPR II), which mediates extracellular to intracellular signal transmission and is involved in carcinogenesis and metastasis. Herein, we...
Autores principales: | Pei, Yao-fei, Zhang, Ya-jing, Lei, Yao, Wu, Ding-wei, Ma, Tong-hui, Liu, Xi-qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410293/ https://www.ncbi.nlm.nih.gov/pubmed/28423564 http://dx.doi.org/10.18632/oncotarget.15513 |
Ejemplares similares
-
Correction: Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer
por: Pei, Yao-fei, et al.
Publicado: (2017) -
CHRDL2 promotes osteosarcoma cell proliferation and metastasis through the BMP‐9/PI3K/AKT pathway
por: Chen, Houping, et al.
Publicado: (2021) -
CHRDL1 Regulates Stemness in Glioma Stem-like Cells
por: Berglar, Inka, et al.
Publicado: (2022) -
Overexpression of colorectal cancer oncogene CHRDL2 predicts a poor prognosis
por: Sun, Jian, et al.
Publicado: (2016) -
CHFR promotes metastasis of human gastric carcinoma by activating AKT and ERK via NRF2- ROS axis
por: He, Feiyun, et al.
Publicado: (2023)